Disclosures
Publications
Many prominent publications in the field of neuromodulation for drug-resistant epilepsy (DRE), obstructive sleep apnea (OSA), and difficult-to-treat depression (DTD) feature scientific experts and recognized leaders dedicated to advancing both neurological and respiratory care, including the development and evaluation of device-based therapies. We are proud that several authors contributing to this important body of research are, or were at the time of publication or presentation, employees of LivaNova PLC. These individuals may hold, or have held, stock or stock options in the company.
This collaboration between LivaNova PLC in-house experts and the broader clinical community reflects our commitment to generating robust, clinically relevant evidence across therapies.
|
Francesca Barion
|
Jason Begnaud
|
Francesca Beraldi
|
|
Andrew Briggs
|
Massimiliano Boffini
|
Haden Carney
|
| Rex Chin-Hao Chen |
Justine Curley
|
Vanessa Danielson
|
|
Maxine Dibue
|
Katherine Eggleston
|
Steffen Fetzer
|
|
Gaia Giannicola
|
Charles Gordon
|
Nadine Juran
|
|
Reginald Lassagne
|
Stephany Mai (Nishikawa) Lee
|
Ying-Chieh Lee
|
|
Eric Lovett
|
Kory Mack
|
David A. Mays
|
|
Joanna Murphy
|
Kathryn Nichol
|
Evan Nicolai
|
|
Tom O'Brien
|
Roshani Patel
|
Robyn van Poelgeest
|
|
Jean Manuel Prudon
|
Pradheep Raman
|
Paolo Roncon
|
|
Elhum Shamshiri
|
Deepika Tungala
|
K. Danielle Urry
|
|
Ryan Verner
|
Alex Moon
|
|
